Skip to main content
LIMN logo

LIMN · Liminatus Pharma, Inc. · Executive Compensation

Track LIMN — free
$3.76 +0.07 (+1.90%) At close · Oct 9
Market Cap
$5.05M
Shares
1.34M
Volume · Oct 9 16.87K Avg daily vol (34 sessions) 34.3K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

No Compensation Data

No Summary Compensation Table has been imported from this company's proxy statements yet.

Executive changes

Person Change Filed
Richard Baek Appointed 2025-07-11
Philip Lemons Appointed 2025-07-11
Sang-jin Daniel Lee Appointed 2025-05-06
Beom K. Choi Appointed 2025-05-06
Byong C. Yoo Appointed 2025-05-06
Chris Kim Appointed 2025-05-06
Scott Dam Appointed 2025-05-06
Lisha Parmar Resigned 2025-05-06
Sumit Mehta Resigned 2025-05-06
Omkar Halady Resigned 2025-05-06
Nicholas Fernandez Appointed 2025-05-06
Eun Sook Lee Appointed 2025-05-06
Ji Yeon Baek Appointed 2025-05-06
Nicholas Fernandez Resigned 2025-05-06
Manish Shah Resigned 2025-05-06
Chris Kim Appointed 2025-05-06
Richard Peretz Resigned 2025-05-06
Rohit Nanani Resigned 2025-05-06
Key facts CIK 1971387 CUSIP 53271X207 13F (30d) 1 filings 1 filers Visit website